Eyelid and periorbital skin resurfacing

What it treats

• The periorbital region shows age before the rest of the face; mild photodamage responds to topical acids and superficial peels, moderate wrinkling to medium-depth peels or erbium laser, and deeper rhytids to CO2 laser, according to a 1999 review of dermatologic periorbital treatments (PMID 9935084).
• Blepharoplasty removes excess skin and fat but does not by itself improve skin texture, which is why patients seeking a fuller rejuvenation combine it with resurfacing (PMID 39921282).
• Phenol peeling is a deep peel that reaches the reticular dermis and is used for scars, deep wrinkles, and lentigos; it is described as an alternative to surgery for eyelid and face rejuvenation in patients who want to avoid an operation (PMID 41472671).
• Constitutional periorbital dark circles, common in skin of color, are a separate indication treated with deep chemical peeling rather than laser (PMID 36735802).
• Upper eyelid dermatochalasis and periorbital rhytidosis can be improved with fractional CO2 laser alone, without an incision, in mild to moderate cases (PMID 28085575).

How it is done

Lasers

• CO2 laser can be delivered as continuous-wave, pulsed, or fractionated (pixelated) energy; fractionation approaches traditional-resurfacing results with fewer side effects (PMID 20166156).
• Erbium:YAG laser causes less thermal spread than CO2; full-field (fully ablative) erbium protocols have defined energy and depth parameters by facial area, including the eyelid (PMID 32110799).
• Combining erbium and CO2 in the same session, with erbium passes first to ablate tissue and a final CO2 pass for hemostasis and added tightening, was described in 1999 as a way to reduce the morbidity of either laser alone (PMID 10334363).
• TCA peel depth for eyelid skin depends on concentration: in a histopathologic study, TCA was applied to preseptal upper-lid skin 48 hours before blepharoplasty at strengths from 20% to 50%, and the tissue was examined for depth of necrosis (PMID 9513236).
• Phenol-croton oil peel formulas for the periorbital area commonly use phenol 60%-65% with croton oil 0.6%-0.7%, applied with the Kligman pre-peel regimen and an occlusive post-peel mask (PMID 36735802), (PMID 41472671).
• A CO2 laser upper blepharoplasty (skin ablation and tightening without a scalpel incision) performed together with erbium resurfacing of the lower lid, in the same session, has been described with an artificial-intelligence model used to grade the photographic result (PMID 39921282).
• Stainless-steel, lubricated corneal eye shields are described as mandatory during any periocular laser treatment, with immediate cessation of the procedure if the patient reports pain or vision change (PMID 40635643).

Results and evidence

• Split-face RCT, 28 patients, fractional CO2 against fractional Er:YAG on opposite sides: wrinkle depth fell about 20% and Fitzpatrick score about 10%, no clear difference between lasers; erbium side effects were worse early, CO2 side effects worse later (PMID 20166156).
• CO2 laser against medium-depth chemical peel, 24 subjects treated on opposite sides: periorbital wrinkle score fell from 4.00 to 1.75 with CO2 against 4.13 to 3.29 with the peel at 6 months, a statistically significant advantage for the laser, though laser-side erythema lasted longer (mean 4.5 months against 2.5 months) (PMID 9256910).
• Split-face collagen study, 16 patients, fractional CO2 applied 30 days before upper blepharoplasty then biopsied: type I collagen intensity was 158.7 in treated skin against 139.2 in untreated skin (p < 0.0001); clinical improvement in periorbital rhytidosis was 23% at 1 month and 43.67% at 6 months after laser plus blepharoplasty (PMID 34618888).
• Ablative fractional CO2 for lower eyelid laxity, 25 patients, 2-3 sessions (mean 2.44): at 6 months, skin texture improved 62.6%, laxity 65.3%, rhytids 62.1%, and overall cosmetic outcome 65.7% (all p < .05) (PMID 21414497).
• Fractional CO2 eyelid tightening, 45 patients followed 1 year: 11.1% rated excellent improvement, 24.5% marked, 33.3% moderate, 31.1% slight; 82.2% also showed a lift in eyebrow position (PMID 21435023).
• Upper eyelid fractional CO2 with incisional upper blepharoplasty, 30 patients: mean rhytidosis improvement 42%, no serious complications, one wound dehiscence that resolved without intervention (PMID 26505229).
• Nonincisional continuous-wave fractional CO2 to the upper lid alone, 6-month follow-up: marginal reflex distance increased from 0.7 to 2.2 mm and palpebral fissure from 5.6 to 7.4 mm; lid crease and lid excursion were unchanged (PMID 28085575).
• Erbium laser series of 625 patients: periocular wrinkles required total fluences of 20-40 J/cm2 for improvement lasting beyond 6 months (PMID 9950553).
• Combined erbium-then-CO2 eyelid resurfacing against CO2 alone: re-epithelialization took 7 days against 12 days, and erythema resolved by 2.5 weeks against 7.0 weeks, with less coagulative dermal damage on histology in the combined group (both p < .05) (PMID 10334363).
• CO2 against erbium collagen-contraction study, 9 patients: vertical tightening was 43% (CO2) and 42% (erbium) at 1 month, easing to 34% and 36% at 6 months; horizontal tightening fell from 31% to 19% with CO2 against a stable 12% for erbium; 3 of 9 erbium-treated lids scarred at the most aggressive settings, none on the CO2 side (PMID 11126433).
• Phenol-croton oil peel for periorbital dark circles, 55 peels in 52 patients: 89% showed more than 50% clinical improvement, with a median duration of improvement of 24 months (range 1.5 to 168 months) and ongoing improvement in 69% at last follow-up (PMID 36735802).
• Ablative CO2 lower eyelid resurfacing, 424 patients: 85.6% were very satisfied and 11.3% satisfied with the aesthetic outcome (PMID 33481534).
• Combined lower eyelid skin-pinch surgery with full-field erbium resurfacing, 25 patients: mean Barton tear-trough score improved from 2.88 to 0.52 (p < .0001) while MRD2 stayed essentially unchanged (3.75 against 3.71 mm, p = .65), and visible lower-lid tightening occurred in 21 of 25 patients (PMID 42108678).
• Tear-film measures after fractional CO2 combined with upper blepharoplasty, 16 patients: all values, including tear break-up time, returned to baseline by 150 days (5 months) with no net worsening (PMID 41467254).

Risks and complications

• TCA depth study: the lowest concentration (20%, single pass) produced necrosis in 30% of epidermal thickness; the strongest combination (50% plus a second 50% pass) produced necrosis into the papillary dermis; cicatricial ectropion risk was judged "very remote" across the tested range, though ectropion has been reported after phenol peels and after deep eyelid peels combined with blepharoplasty (PMID 9513236).
• A review of 4 cases of scarring or ectropion after fractional CO2 resurfacing named the eyelid among the more sensitive sites; contributing factors included aggressive energy or density, one methicillin-resistant Staphylococcus aureus infection, and technique inexperience (PMID 19291745).
• In 424 ablative CO2 lower-eyelid patients: contact dermatitis in 5.2%, postinflammatory hyperpigmentation in 9.4% (all eventually resolved), localized herpetic outbreak in under 1%, atypical mycobacterial infection in 0.5%, and a small scar in 0.9%; no persistent scarring or ectropion (PMID 33481534).
• In the 625-patient erbium series: scarring 0.8%, temporary hyperpigmentation 3.4%, mild hypopigmentation 4.0%, temporary scleral show 0.6%, lower-lid synechiae 1.3%; no permanent ectropion (PMID 9950553).
• Full-field erbium complication rates rise with depth: 10.1% for superficial MicroLaserPeel (198 cases) against 26.5% for deep resurfacing (268 cases); the eyelid's deep-resurfacing rate fell in a 15.2%-20.9% range with the cheek, nose, and forehead (PMID 32110799).
• Periorbital fractionated CO2 as a blepharoplasty adjunct, 59 patients: 6 (10.2%) had a side effect, including hyperpigmentation (5.1%) and lower eyelid retraction requiring surgical recession (1.7%); no infections (PMID 35947796).
• Postinflammatory hyperpigmentation after CO2 resurfacing generally occurs in up to 20%-30% of patients, per background cited in a case study of prophylactic photobiomodulation used to reduce it (PMID 38776545).
• Phenol peel complications can include arrhythmia, skin atrophy, scarring, acne eruption, and infection; none occurred in a small case series of 4 eyelid phenol-peel patients (PMID 41472671).
• Combined skin-pinch and full-field erbium resurfacing, 25 patients: transient chemosis in 6 and prolonged erythema in 2, both resolving conservatively; no ectropion, retraction, or new scleral show (PMID 42108678).
• Recognized ocular risks of laser near the eye include corneal burns, infection, dry eye, cataract, and blindness, which is why corneal eye shields are part of expert-panel safety protocol (PMID 40635643).

Recovery

• Combining erbium and CO2 laser in one eyelid protocol shortened re-epithelialization to 7 days (against 12 days for CO2 alone) and erythema to 2.5 weeks (against 7.0 weeks) (PMID 10334363).
• CO2 laser produced longer-lasting erythema than a medium-depth chemical peel in a head-to-head periorbital comparison, 4.5 months against 2.5 months on average (PMID 9256910).
• Ablative fractional CO2 for lower-lid laxity: moderate erythema and edema resolved by 1 week, with minor crusting and oozing resolving within 48 to 72 hours (PMID 21414497).
• Continuous-wave fractional CO2 to the upper lid: postoperative erythema, edema, crusting, and oozing resolved within 14 days (PMID 28085575).
• Tear-film measures after combined blepharoplasty and fractional CO2 resurfacing returned to preoperative baseline by 150 days, without net worsening of dry-eye risk over that period (PMID 41467254).
• A tested post-procedure cream reduced erythema by day 3 and restored pre-procedure skin tone by day 7 after full-field erbium lower-eyelid resurfacing, compared with a standard anhydrous topical (PMID 40911753).
• Phenol peel aftercare in one protocol used an occlusive mask, no washing of the area for 7 to 10 days, lubricating eye drops, and oral analgesics as needed (PMID 41472671).
• In one TCA protocol, the peel was applied 48 hours before blepharoplasty so the chemical injury and the surgical healing window overlapped (PMID 9513236).

Combined procedures

• Periorbital CO2 resurfacing as an adjunct to lower blepharoplasty, even at higher-energy settings, produced no infections in 59 patients, with all satisfied at final follow-up (PMID 35947796).
• Upper-lid fractional CO2 combined with incisional upper blepharoplasty can reduce or remove the need for a separate medial-canthal skin excision while treating residual pretarsal and sub-brow wrinkles (PMID 26505229).
• Skin-pinch lower blepharoplasty has been combined with full-field erbium resurfacing, tear-trough fat grafting, orbital retaining ligament release, and canthopexy in one protocol (PMID 42108678); canthopexy is covered in canthoplasty and canthopexy and fat grafting/ligament release in tear trough and lid-cheek junction surgery.
• The excision techniques these resurfacing methods are paired with are covered in upper blepharoplasty and lower blepharoplasty.

Current questions

• CO2 against erbium: a split-face RCT found roughly equivalent wrinkle reduction with no clear preference (PMID 20166156), while an earlier study found similar early tightening from both but more scarring from aggressive erbium passes (PMID 11126433); choice still varies by surgeon and downtime tolerance.
• Fractional against fully ablative treatment on thin eyelid skin is a narrow margin for error: full-field erbium reports complication rates as high as 15%-27% by depth even in an experienced practice (PMID 32110799), while newer fractional and combined protocols report low rates of ectropion or retraction (PMID 33481534), (PMID 42108678).
• Whether resurfacing substitutes for blepharoplasty or only supplements it is unsettled: one phenol peel case series frames peeling as a surgical alternative (PMID 41472671), while most recent CO2 and erbium series describe resurfacing as an add-on to blepharoplasty (PMID 35947796), (PMID 26505229).
• Durability of chemical peel results for periorbital dark circles varied from 1.5 to 168 months around a 24-month median in one series, a range not yet explained (PMID 36735802).
• Reducing postinflammatory hyperpigmentation, reported in up to 20%-30% of CO2 resurfacing patients generally, is an active area; prophylactic photobiomodulation helped in a single published case and has not been trialed (PMID 38776545).
• Artificial-intelligence grading of periorbital laser photographs is new, reported only by the group that built the model (PMID 39921282).

Terms

• Ablative laser resurfacing: laser treatment that vaporizes the skin surface to induce new collagen and tightening, using CO2 or erbium:YAG wavelengths (PMID 9935084).
• Fractional (fractionated) laser: delivery of ablative energy in a pixelated pattern that leaves untreated skin between treatment spots to speed healing, as opposed to fully ablative (full-field) treatment (PMID 20166156).
• Erbium:YAG laser: an ablative laser with less thermal spread into surrounding tissue than CO2, associated with faster re-epithelialization (PMID 32110799).
• TCA (trichloroacetic acid) peel: a chemical peel whose depth of skin injury increases with concentration and number of passes (PMID 9513236).
• Phenol (phenol-croton oil) peel: a deep chemical peel reaching the reticular dermis, used for deep wrinkles and pigment change (PMID 36735802).
• Rhytid(s): a wrinkle or fine line, the treatment target of resurfacing (PMID 21414497).
• Postinflammatory hyperpigmentation (PIH): darkening of treated skin during healing, a common resurfacing side effect (PMID 38776545).
• Cicatricial ectropion: scar-related outward turning of the eyelid margin, the complication periorbital peels and lasers are managed to avoid (PMID 9513236).
• MRD1 / MRD2: distances from the corneal light reflex to the upper and lower eyelid margins, used to confirm lid position is unchanged after resurfacing (PMID 42108678).
• Dermatochalasis: excess, lax eyelid skin, the condition fractional CO2 has been used to soften without an incision (PMID 28085575).

Papers